Summary
Cardiac contraction is dependent on a rapid alteration of the intracellular Ca2+ concentration, especially the Ca2+ released during systole. In end-stage heart failure, cardiac contractility is depressed due to alterations in the structure and function of proteins or protein complexes. Over recent years, new insights have been obtained regarding the regulation of the intracellular Ca2+ homeostasis and its pathophysiological alteration in end-stage heart failure. This review focuses on the mechanisms involved in the release of Ca2+ from the sarcoplasmic reticulum (SR) during systole via the ryanodine receptors and the Ca2+-uptake into the SR by the sarcoplasmic reticulum Ca2+-ATPase (SERCA 2a). In addition, new therapeutic options will be introduced which may be of importance for the treatment of heart failure patients.
Zusammenfassung
Die Funktion der Herzmuskelzelle beruht auf einem schnellen Wechsel der intrazellulären Ca2+-Konzentration und ist dabei wesentlich von der während der Systole in das Zytoplasma freigesetzten Ca2+-Konzentration abhängig. Bei der Herzinsuffizienz ist die kardiale Kontraktilität durch Veränderungen in der Struktur und Funktion von Proteinen/Proteinkomplexen gestört. In den letzten Jahren wurden neue Erkenntnisse im Hinblick auf die Regulation der intrazellulären Ca2+-Homöostase und ihre pathophysiologischen Veränderungen im Endstadium der Herzinsuffizienz gewonnen, die für die Therapie der Herzinsuffizienz von Bedeutung sind. Dies betrifft insbesondere die Vorgänge der Ca2+-Freisetzung aus dem sarkoplasmatischen Retikulum (SR) über die Ryanodin-Rezeptoren sowie die Ca2+-Aufnahme in das SR durch die sarkoplasmatische Ca2+-ATPase (SERCA 2a). Der vorliegende Artikel fasst aktuelle Forschungsergebnisse zusammen und zeigt neue Therapieoptionen auf, die sich hieraus ergeben können.
Similar content being viewed by others
Literatur
Schwinger RHG, Hoischen S, Reuter H, Hullin R (1999) Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts. J Mol Cell Cardiol 31: 283–296
Schroder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, Schwinger RHG, Weil J, Herzig S (1998) Increased availability and open probability of single L-type calcium channels from failing compared with non-failing human ventricle. Circulation 98: 969–976
Mewes T, Ravens U (1994) L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium. J Mol Cell Cardiol 26: 1307–1320
Beuckelmann DJ, Erdmann E (1992) Ca2+-currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Basic Res Cardiol 87 (Suppl 1): 235–243
Piot C, Lemaire S, Albat B, Seguin J, Nargeot J, Richard S (1996) High frequency-induced upregulation of human cardiac calcium currents. Circulation 93: 120–128
Fabiato A, Fabiato F (1975) Contractions induced by a calcium-triggered release of calcium from the sarcoplasmic reticulum of single skinned cardiac cells. J Physiol 249: 469–495
Wehrens XH, Marks AR (2004) Novel therapeutic approaches for heart failure by normalizing calcium cycling. Nat Rev Drug Discov 3: 565–573
Most P, Bernotat J, Ehlermann P, Pleger ST, Reppel M, Borries M, Niroomand F, Pieske B, Janssen PM, Eschenhagen T, Karczewski P, Smith GL, Koch WJ, Katus HA, Remppis A (2001) S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A 98: 13889–13894
Lehnart SE, Wehrens XH, Kushnir A, Marks AR (2004) Cardiac ryanodine receptor function and regulation in heart disease. Ann N Y Acad Sci 1015: 144–159
Munch G, Bolck B, Sugaru A, Brixius K, Bloch W, Schwinger RHG (2001) Increased expression of isoform 1 of the sarcoplasmic reticulum Ca(2+)-release channel in failing human heart. Circulation 103: 2739–2744
Yano M, Ikeda Y, Matsuzaki M (2005) Altered intracellular Ca2+-handling oin heart failure. J Clin Invest 115: 556–564
Frank KF, Boelck B, Hattebuhr N, Malik AS, Schwinger RHG (2004) Decreased Ca2+-dependent binding of sorcin to annexin VII and Ca2+-release channel in human failing myocardium. Eur Heart Journal 24: 58
Remppis A, Greten T, Schafer BW, Hunziker P, Erne P, Katus HA, Heizmann CW (1996) Altered expression of the Ca2+-binding protein S100A1 in human cardiomyopathy. Biochim Biophys Acta 1313: 253–257
Frank KF, Bolck B, Erdmann E, Schwinger RHG (2003) Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res 57: 20–27
Schwinger RHG, Bohm M, Schmidt U, Karczewski P, Bavendiek U, Flesch M, Krause EG, Erdmann E (1995) Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220–3228
Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, et al (1994) Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434–442
Beuckelmann DJ, Nabauer M, Erdmann E (1992) Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85: 1046–1055
Brixius K, Wollmer A, Bolck B, Mehlhorn U, Schwinger RHG (2003) Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium. Pflugers Arch 447: 150–157
Philipson KD, Nicoll DA, Ottolia M, Quednau BD, Reuter H, et al. (2002) The Na+/Ca2+ exchange molecule: an overview. Ann N Y Acad Sci 976: 1–10
Pieske B, Maier LS, Piacentino V, 3rd, Weisser J, Hasenfuss G, Houser S (2002) Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation 106: 447–453
Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H (1994) Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. Circ Res 75: 434–442
Klotz S, Barbone A, Reiken S, Holmes JW, Naka Y, Oz MC, Marks AR, Burkhoff D (2005) Left ventricular assist device support normalizes left and right ventricular betaadrenergic pathway properties. J Am Coll Cardiol 45: 668–676
Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D (2000) Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102: 2713–2719
Muller OJ, Lange M, Rattunde H, Lorenzen HP, Muller M, Frey N, Bittner C, Simonides W, Katus HA, Franz WM (2003) Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res 59: 380–389.
del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec GW, Gwathmey JK, Rosenzweig A, Hajjar RJ (1999) Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation 100: 2308–2311
del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ (2002) Targeting phospholamban by gene transfer in human heart failure. Circulation 105: 904–907
Pathak A, del Monte F, Zhao W, Schultz JE, Lorenz JN, Bodi I, Bodi I, Weiser D, Hahn H, Carr AN, Syed F, Mavila N, Jha L, Qian J, Marreez Y, Chen G, McGraw DW, Heist EK, Guerrero JL, DePaoli-Roach AA, Hajjar RJ, Kranias EG (2005) Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res 96: 756–766.
Prestle J, Janssen PM, Janssen AP, Zeitz O, Lehnart SE, et al (2001) Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptormediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. Circ Res 88: 188–194
Frank KF, Bolck B, Ding Z, Krause D, Hattebuhr N, Malik A, Brixius K, Hajjar RJ, Schrader J, Schwinger RHG (2005) Overexpression of sorcin enhances cardiac contractility in vivo and in vitro. J Mol Cell Cardiol 38: 607–615
Reiken S, Wehrens XH, Vest JA, Barbone A, Klotz S, Mancini D, Burkhoff D, Marks AR (2003) Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107: 2459–2466
Reiken S, Gaburjakova M, Gaburjakova J, He Kl KL, Prieto A, Becker E, Yi GH, Wang J, Burkhoff D, Marks AR (2001) Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation 104: 2843–2848
Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819–823
Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR (2002) Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 346: 1357–1365
Sigmund M, Jakob H, Becker H, Hanrath P, Schumacher C, Eschenhagen T, Schmitz W, Scholz H, Steinfath M (1996) Effects of metoprolol on myocardial beta-adrenoceptors and Gi alpha-proteins in patients with congestive heart failure. Eur J Clin Pharmacol 51: 127–132
Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisaoka T, Obayashi M, Ohkusa T, Kohno M, Matsuzaki M (2003) FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107: 477–484
Ohizumi Y, Sasaki S, Shibusawa K, Ishikawa K, Ikemoto F (1996) Stimulation of sarcoplasmic reticulum Ca(2+)-ATPase by gingerol analogues. Biol Pharm Bull 19: 1377–1379
Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, Mende U, Kranias EG, MacLennan DH, Seidman JG, Seidman CE (2003) Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299: 1410–1413
Bolck B, Munch G, Mackenstein P, Hellmich M, Hirsch I, Reuter H, Hattebuhr N, Weig HJ, Ungerer M, Brixius K, Schwinger RHG (2004) Na+/Ca2+ exchanger overexpression impairs frequency- and ouabain-dependent cell shortening in adult rat cardiomyocytes. Am J Physiol 287: H1435–H1445
Hobai IA, Maack C, O'Rourke B (2004) Partial inhibition of sodium/calcium exchange restores cellular calcium handling in canine heart failure. Circ Res 95: 292–299
Most P, Remppis A, Pleger ST, Loffler E, Ehlermann P, Bernotat J, Kleuss C, Heierhorst J, Ruiz P, Witt H, Karczewski P, Mao L, Rockman HA, Duncan SJ, Katus HA, Koch WJ (2003) Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance. J Biol Chem 278: 33809–33817
Mathew J, Hunsberger S, Fleg J, Mc Sherry F, Williford W, Yusuf S (2000) Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 118: 914–922
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brixius, K., Frank, K., Bölck, B. et al. Reverses Remodeling der intrazellulären Ca2+-Homöostase: Neue Konzepte zur Pathophysiologie und Therapie der Herzinsuffizienz. Wien Med Wochenschr 156, 209–215 (2006). https://doi.org/10.1007/s10354-005-0239-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10354-005-0239-4